Janelle Bradley

NCCN Updates Clinical Practice Guideline for Small Cell Lung Cancer
Guideline Updates
NCCN Updates Clinical Practice Guideline for Small Cell Lung Cancer
03/24/2021
NCCN released an update to its clinical practice guideline for small cell lung cancer, featuring modifications for supportive care and subsequent systemic therapy.
NCCN released an update to its clinical practice guideline for small cell lung cancer, featuring modifications for supportive care and subsequent systemic therapy.
NCCN released an update to its...
03/24/2021
Journal of Clinical Pathways
Conference Coverage
Epcoritamab Plus Rituximab and Lenalidomide Yields High Complete Metabolic Response Rate in Follicular Lymphoma
12/16/2022
In patients with relapsed or refractory follicular lymphoma, epcoritamab combined with rituximab and lenalidomide demonstrated manageable safety and a high complete metabolic response rate, according to findings from a phase 1/2 study.
In patients with relapsed or refractory follicular lymphoma, epcoritamab combined with rituximab and lenalidomide demonstrated manageable safety and a high complete metabolic response rate, according to findings from a phase 1/2 study.
In patients with relapsed or...
12/16/2022
Oncology
Conference Coverage
Safety and Cost-Effectiveness of CAR-T Therapy in the Outpatient vs Inpatient Setting
12/08/2021
Study findings presented at the 2021 ASH Annual Meeting demonstrate the feasibility and cost-effectiveness of outpatient administration of CAR-T therapy for patients with hematologic malignancies.
Study findings presented at the 2021 ASH Annual Meeting demonstrate the feasibility and cost-effectiveness of outpatient administration of CAR-T therapy for patients with hematologic malignancies.
Study findings presented at the...
12/08/2021
Journal of Clinical Pathways
News
Long-term Incidence of Hematuria Following Post-Prostatectomy Radiotherapy
05/25/2022
Hematuria is common following post-prostatectomy radiotherapy, particularly among patients with medication allergies and those on anticoagulation/antiplatelet therapy, according to a study published in the Journal of Urology.
Hematuria is common following post-prostatectomy radiotherapy, particularly among patients with medication allergies and those on anticoagulation/antiplatelet therapy, according to a study published in the Journal of Urology.
Hematuria is common following...
05/25/2022
Oncology
Conference Coverage
Biomarker Testing and Alpelisib Treatment Patterns for Metastatic Breast Cancer in the Community Oncology Setting
12/07/2021
A study presented at the 2021 San Antonio Breast Cancer Symposium assessed PIK3CA testing and alpelisib treatment patterns among patients with metastatic breast cancer in the community oncology setting.
A study presented at the 2021 San Antonio Breast Cancer Symposium assessed PIK3CA testing and alpelisib treatment patterns among patients with metastatic breast cancer in the community oncology setting.
A study presented at the 2021...
12/07/2021
Journal of Clinical Pathways
News
Systematic Review Highlights Complexity of Cost-Effectiveness Models in Prostate Cancer
02/22/2022
This systematic review of cost-effectiveness literature for novel diagnostic methods in prostate cancer shows that most studies have found novel methods to be more cost-effective than standard of care.
This systematic review of cost-effectiveness literature for novel diagnostic methods in prostate cancer shows that most studies have found novel methods to be more cost-effective than standard of care.
This systematic review of...
02/22/2022
Journal of Clinical Pathways
Conference Coverage
Panitumumab Plus mFOLFOX6 Significantly Improves OS in Metastatic Colorectal Cancer
06/29/2022
Findings from the phase 3 PARADIGM trial reveal panitumumab combined with mFOLFOX6 significantly improved OS vs bevacizumab plus mFOLFOX6 among patients with RAS wild-type and left-sided metastatic colorectal cancer.
Findings from the phase 3 PARADIGM trial reveal panitumumab combined with mFOLFOX6 significantly improved OS vs bevacizumab plus mFOLFOX6 among patients with RAS wild-type and left-sided metastatic colorectal cancer.
Findings from the phase 3...
06/29/2022
Oncology
Conference Coverage
Novel Agents Preferable to Standard Chemotherapy for Salvage Treatment in LBCL Progressing After CAR-T Therapy
12/11/2022
Salvage treatment with polatuzumab-containing and bispecific antibody-based regimens is preferable to standard chemotherapy for patients with relapsed/refractory LBCL, according to study findings.
Salvage treatment with polatuzumab-containing and bispecific antibody-based regimens is preferable to standard chemotherapy for patients with relapsed/refractory LBCL, according to study findings.
Salvage treatment with...
12/11/2022
Oncology
News
Pertuzumab Added to Trastuzumab and Chemotherapy Improves Outcomes in Metastatic Breast Cancer
03/22/2022
Findings from a real-world study suggest the addition of pertuzumab to trastuzumab and chemotherapy improves safety and OS for patients with metastatic breast cancer.
Findings from a real-world study suggest the addition of pertuzumab to trastuzumab and chemotherapy improves safety and OS for patients with metastatic breast cancer.
Findings from a real-world study...
03/22/2022
Journal of Clinical Pathways
NCCN Updates Clinical Practice Guideline for Kidney Cancer
NCCN Updates Clinical Practice Guideline for Kidney Cancer
03/24/2021
On March 23, 2021, the National Comprehensive Cancer Network (NCCN) released an update to its clinical practice guideline for kidney cancer.
On March 23, 2021, the National Comprehensive Cancer Network (NCCN) released an update to its clinical practice guideline for kidney cancer.
On March 23, 2021, the National...
03/24/2021
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use